Global Pathology Analysis & Statistics, August 2014 (p2)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

You might be interested in: Cancer, Breast Cancer, Leukemia, more »

31-80 of about 1 900 reports

Purchase Reports From Reputable Market Research Publishers

Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023

Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Fluticasone Furoate (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluticasone Furoate (Asthma) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, Australia, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023

Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Bosatria (Mepolizumab) (Asthma) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023

Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Benralizumab (Asthma) - Forecast and Market Analysis to 2023

Benralizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Benralizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Benralizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Dupilumab (Asthma) - Forecast and Market Analysis to 2023

Dupilumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Dupilumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Dupilumab (Asthma) - Forecast and Market Analysis to 2023”. The ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Quilizumab (Asthma) - Forecast and Market Analysis to 2023

Quilizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Quilizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quilizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Tralokinumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tralokinumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Diabetes, Metabolic Syndrome and Cardiovascular Disease

Diabetes, Metabolic Syndrome and Cardiovascular Disease

  • $ 3 400
  • Industry report
  • November 2014
  • by TriMark Publications

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes ...

  • Industries : Pathology
  • Countries : World, United States
Global Influenza Market 2014-2018

Global Influenza Market 2014-2018

  • $ 3 000
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Influenza Influenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to severe illness. The disease can be fatal in some ...

  • Industries : Pathology
  • Countries : World
North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

  • $ 3 000
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

North America autoimmune disease diagnostics market is estimated to reach $7.09 billion in 2020 from $5.504 billion in 2014 with a CAGR 5.24%. The term “autoimmune disease” ...

  • Industries : Pathology
  • Countries : North America
Global Hepatitis C Market 2014-2018

Global Hepatitis C Market 2014-2018

  • $ 3 000
  • Industry report
  • September 2014
  • by Infiniti Research Limited

About Hepatitis C Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Asthma - Current and Future Players

PharmaPoint: Asthma - Current and Future Players

  • $ 2 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Asthma - Current and Future Players”. The report is a vital source of up-to-date information ...

  • Industries : Pathology
  • Countries : World
Global Epilepsy Market 2014-2018

Global Epilepsy Market 2014-2018

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Epilepsy Epilepsy is defined as a spectrum of brain disorders varying from benign symptoms to severe, disabling, and life-threatening symptoms. It can be caused by various factors ranging from brain ...

  • Industries : Pathology
  • Countries : World
Global Fabry Disease Market 2015-2019

Global Fabry Disease Market 2015-2019

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Fabry Disease Fabry disease is an inheritable lysosomal storage disease characterized by the excessive accumulation of globotriaosylceramide (GL-3) in lysosomes. It results from a deficiency of a-Gal ...

  • Industries : Pathology
  • Countries : World
Global Acne Market 2014-2018

Global Acne Market 2014-2018

  • $ 2 500
  • Industry report
  • November 2014
  • by Infiniti Research Limited

About Acne Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is ...

  • Industries : Pathology
  • Countries : World
Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data ...

  • Industries : Pathology
  • Countries : World
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chronic Cutaneous Lupus Erythematosus ...

  • Industries : Pathology
  • Countries : World
Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014" ...

  • Industries : Pathology
  • Countries : World
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on ...

  • Industries : Pathology
  • Countries : World
Global Glaucoma Devices Market 2014-2018

Global Glaucoma Devices Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Glaucoma Glaucoma is a long-lasting, permanent condition that does not cause immediate blindness. Glaucoma is a disease that damages the eye's optic nerve. This disease is often called the “sneak ...

  • Industries : Pathology
  • Countries : World
Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from ...

  • Industries : Pathology
  • Countries : World
Global Digital Pathology Market 2014-2018

Global Digital Pathology Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Global Digital Pathology Digital pathology includes managing, interpreting, and analysing the digital information. It also termed as virtual microscopy or virtual pathology. It includes the process ...

  • Industries : Pathology
  • Countries : World
Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018

Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About COPD COPD is a broad term that covers various progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It is a serious ...

  • Industries : Pathology
  • Countries : World
Global Pancreatic Cancer Market 2014-2018

Global Pancreatic Cancer Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Pancreatic Cancer Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine ...

  • Industries : Pathology
  • Countries : World
Global Premature Ejaculation Market 2014-2018

Global Premature Ejaculation Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Premature Ejaculation Premature ejaculation is a common sexual dysfunction in men, which is characterized by early discharge of semen. Premature ejaculation can be diagnosed through IELT, which is ...

  • Industries : Pathology
  • Countries : World
Global Non-small Cell Lung Cancer Market 2014-2018

Global Non-small Cell Lung Cancer Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cance ...

  • Industries : Pathology
  • Countries : World
Global Asthma Market 2014-2018

Global Asthma Market 2014-2018

  • $ 2 500
  • Industry report
  • September 2014
  • by Infiniti Research Limited

About Asthma and its Categories Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, ...

  • Industries : Pathology
  • Countries : World
Asthma - Pipeline Review, H2 2014, Global Markets Direct

Asthma - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 500
  • Industry report
  • August 2014
  • by Global Markets Direct

Asthma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Asthma - Pipeline Review, H2 2014', provides an overview of the Asthma's therapeutic pipeline. This report provides comprehensive information ...

  • Industries : Pathology
  • Countries : World
Prostate Cancer - Pipeline Review, H2 2014, Global Markets Direct

Prostate Cancer - Pipeline Review, H2 2014, Global Markets Direct

  • $ 2 500
  • Industry report
  • August 2014
  • by Global Markets Direct

Prostate Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Prostate Cancer - Pipeline Review, H2 2014', provides an overview of the Prostate Cancer's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
About 3 600 reports

Download Unlimited Documents from Trusted Public Sources

Global Pathology Description

  • November 2014
    95 pages
  • Hiv  

  • Kenya  

    Africa  

    World  

View report >

83 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.